PD-L1-R: A MR based surrogate for PD-L1 expression in Glioblastoma multiforme.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.2041
Abstract: 2041Background: Efficacy of PD-L1 immune checkpoint inhibitor therapy in Glioblastoma multiforme (GBM) is limited and the prognostic value of PD-L1 in GBM is an active field of research. We therefo... read more here.
Keywords: glioblastoma; surrogate expression; expression glioblastoma; based surrogate ... See more keywords
PD-L1 Expression in Glioblastoma, the Clinical and Prognostic Significance: A Systematic Literature Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.01015
Abstract: Background: The clinical and prognostic value of programmed death-ligand 1, PD-L1, in glioblastoma remains controversial. The present study aimed to identify the expression of PD-L1 for its prognostic value in glioblastoma. Methods: A comprehensive literature… read more here.
Keywords: glioblastoma; meta analysis; clinical prognostic; expression ... See more keywords
Bioinformatic analysis of the potential molecular mechanism of PAK7 expression in glioblastoma
Sign Up to like & getrecommendations! Published in 2020 at "Molecular Medicine Reports"
DOI: 10.3892/mmr.2020.11206
Abstract: The present study aimed to determine the potential molecular mechanisms underlying p21 (RAC1)-activated kinase 7 (PAK7) expression in glioblastoma (GBM) and evaluate candidate prognosis biomarkers for GBM. Gene expression data from patients with GBM, including… read more here.
Keywords: analysis; expression; potential molecular; pak7 expression ... See more keywords